Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anatomy of the Eyeball01:20

Anatomy of the Eyeball

11.0K
The eye is a spherical, hollow structure composed of three tissue layers. The outer layer — the fibrous tunic, comprises the sclera — a white structure — and the cornea, which is transparent. The sclera encompasses some of the ocular surface, most of which is not visible. However, the 'white of the eye' is distinctively visible in humans compared to other species. The cornea, a clear covering at the front of the eye, enables light penetration. The eye's middle...
11.0K
The Retina01:32

The Retina

78.1K
The retina is a layer of nervous tissue at the back of the eye that transduces light into neural signals. This process, called phototransduction, is carried out by rod and cone photoreceptor cells in the back of the retina.
78.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continuous heart rate variability monitoring, stress and recovery in doctors: a systematic review and meta-analysis.

Occupational medicine (Oxford, England)·2025
Same author

How to spot the recurring lumbar disc? Risk factors for recurrent lumbar disc herniation (rLDH) in adult patients with lumbar disc prolapse: a systematic review and meta-analysis.

Acta orthopaedica Belgica·2023
Same author

Distal retinal ganglion cell axon transport loss and activation of p38 MAPK stress pathway following VEGF-A antagonism.

Cell death & disease·2016
Same author

Broadening our focus in the search for cell transplantation-based glaucoma therapies.

Eye (London, England)·2011
Same author

Transplantation prospects for the inner retina.

Eye (London, England)·2008
Same author

Stem cells for neuroprotection in glaucoma.

Progress in brain research·2008
Same journal

The NHS Diabetic Eye Screening Programme: Insights from a Research and Innovation Needs Assessment.

Eye (London, England)·2026
Same journal

Socioeconomic inequalities in self-reported vision impairment among middle-aged and older adults in China: a national longitudinal study from 2011 to 2018.

Eye (London, England)·2026
Same journal

Advanced glaucoma without cupping in the setting of large optic disc drusen and high myopia.

Eye (London, England)·2026
Same journal

The giant behind the swollen disc: bilateral papilloedema heralding a silent brain tumour in tuberous sclerosis complex.

Eye (London, England)·2026
Same journal

Anterior chamber cholesterolosis in advanced Coats disease.

Eye (London, England)·2026
Same journal

Digital microscopy of demodex microbubble encirclement after lotilaner 0.25.

Eye (London, England)·2026
See all related articles

Related Experiment Video

Updated: Mar 8, 2026

Isolation of Primary Murine Retinal Ganglion Cells RGCs by Flow Cytometry
11:01

Isolation of Primary Murine Retinal Ganglion Cells RGCs by Flow Cytometry

Published on: July 5, 2017

16.3K

Protecting retinal ganglion cells.

T Z Khatib1,2, K R Martin1,2,3,4

  • 1Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK.

Eye (London, England)
|January 14, 2017
PubMed
Summary
This summary is machine-generated.

Emerging neuroprotection strategies, including stem cells and gene therapy, offer hope for retinal ganglion cell degeneration in glaucoma. Further research and clinical trials are needed to overcome potential challenges and restore vision.

More Related Videos

Retrograde Labeling of Retinal Ganglion Cells by Application of Fluoro-Gold on the Surface of Superior Colliculus
14:05

Retrograde Labeling of Retinal Ganglion Cells by Application of Fluoro-Gold on the Surface of Superior Colliculus

Published on: June 17, 2008

15.9K
Morphometric Analyses of Retinal Sections
14:33

Morphometric Analyses of Retinal Sections

Published on: February 19, 2012

10.8K

Related Experiment Videos

Last Updated: Mar 8, 2026

Isolation of Primary Murine Retinal Ganglion Cells RGCs by Flow Cytometry
11:01

Isolation of Primary Murine Retinal Ganglion Cells RGCs by Flow Cytometry

Published on: July 5, 2017

16.3K
Retrograde Labeling of Retinal Ganglion Cells by Application of Fluoro-Gold on the Surface of Superior Colliculus
14:05

Retrograde Labeling of Retinal Ganglion Cells by Application of Fluoro-Gold on the Surface of Superior Colliculus

Published on: June 17, 2008

15.9K
Morphometric Analyses of Retinal Sections
14:33

Morphometric Analyses of Retinal Sections

Published on: February 19, 2012

10.8K

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Regenerative Medicine

Background:

  • Retinal ganglion cell (RGC) degeneration causes severe vision loss in conditions like glaucoma.
  • Current treatments for RGC degeneration are limited, necessitating novel therapeutic approaches.

Purpose of the Study:

  • To review emerging neuroprotection strategies for RGC degeneration, focusing on glaucoma.
  • To discuss the potential of pharmacological, stem cell, and gene therapy interventions.
  • To identify challenges and future directions for clinical translation.

Main Methods:

  • Literature review of recent advancements in neuroprotection for RGCs.
  • Analysis of pharmacological agents, mesenchymal stem cells, and gene therapy.
  • Discussion of potential pitfalls and clinical trial prospects.

Main Results:

  • Pharmacological agents, mesenchymal stem cells, and gene therapy show promise for RGC neuroprotection.
  • Several challenges, including delivery and efficacy, need to be addressed for these strategies.
  • Clinical trials are a crucial next step for validating these therapeutic approaches.

Conclusions:

  • Emerging neuroprotection strategies offer new hope for treating RGC degeneration in glaucoma.
  • Careful consideration of potential pitfalls is essential for successful development.
  • Future research and clinical trials will determine the efficacy of these interventions.